This essay analyzes the subject positioning demanded by randomized control trials (RCT). Taking seriously the fact that people in late-stage cancer treatments will die, even if one arm of the study receives a “successful” treatment, Jain argues that the RCT framework carries a politics belied by its status as an objective research method.
S. Lochlann Jain; The Mortality Effect: Counting the Dead in the Cancer Trial. Public Culture 1 January 2010; 22 (1): 89–117. doi: https://doi.org/10.1215/08992363-2009-017
Download citation file: